Stock PHARM PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

News Pharming Group N.V.

Equities

PHARM

NL0010391025

Real-time Euronext Amsterdam
Other stock markets
 04:53:35 2024-05-07 am EDT 		5-day change 1st Jan Change
0.8995 EUR -0.06% Intraday chart for Pharming Group N.V. +2.68% -12.71%
Apr. 22 Pharming Group to Buy Back EUR123 Million of Bonds due 2025 MT
Apr. 18 Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K
PU
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards
AQ
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K
PU
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
PU
Pharming Group to report first quarter 2024 financial results on May 8
GL
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
GL
Pharming Group to Buy Back EUR123 Million of Bonds due 2025
MT
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
GL
Pharming N : Pharming Group announces the placement of €100 million convertible bonds due 2029
PU
Pharming Group announces the placement of €100 million convertible bonds due 2029
GL
Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds
MT
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
GL
Pharming Group N.V. announced that it expects to receive ?100 million in funding
CI
Pharming Group N.V. Announces Completion of Enrollment in Pediatric Clinical Trial of Leniolisib
CI
Pharming Group Finishes Enrolling Patients for Phase 3 Pediatric Testing of its Treatment for Rare Auto-Immune Disorder
MT
Pharming N : Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
PU
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GL
Pharming N : Pharming Group announces the 2024 Annual General Meeting of Shareholders
PU
Pharming N : Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
PU
Pharming N : Notice to Convene AGM 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. News Pharming Group N.V.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW